Navigation Links
Anadys Pharmaceuticals to Report Second Quarter 2011 Financial Results
Date:8/2/2011

SAN DIEGO, Aug. 2, 2011 /PRNewswire/ -- Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS) announced today that it will report second quarter 2011 financial results on Monday, August 8, 2011, after the U.S. financial markets close.

Anadys will hold a conference call and webcast on Monday, August 8, 2011, at 5:00 p.m. Eastern Daylight Time to discuss its second quarter 2011 financial results and highlights.  A live webcast of the call will be available online at www.anadyspharma.com.  A telephone replay will also be available approximately one hour after completion of the call.  To access the telephone replay, dial 888-286-8010 (domestic) or 617-801-6888 (international), passcode 39592231.  The webcast and telephone replay will be available through August 22, 2011.

About Anadys

Anadys Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to improving patient care by developing novel medicines for the treatment of hepatitis C.  The Company believes hepatitis C represents a large unmet medical need in which meaningful improvements in treatment outcomes may be attainable with the introduction of new medicines.  Anadys is conducting a Phase IIb study of setrobuvir, the Company's DAA, added to pegylated interferon and ribavirin for the treatment of hepatitis C.  The Company is also preparing to resume clinical development of ANA773, the Company's oral, small-molecule inducer of endogenous interferons that acts via the Toll like receptor 7, or TLR7, pathway in hepatitis C.

Safe Harbor Statement

Statements in this press release that are not strictly historical in nature constitute "forward-looking statements."  Such statements include, but are not limited to, references to Anadys' strategy, development programs, and ability to develop novel medicines for the
'/>"/>

SOURCE Anadys Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Anadys Highlights ANA773 Data to be Presented at ASCO
2. Anadys Pharmaceuticals to Report First Quarter 2011 Financial Results
3. Anadys Pharmaceuticals Reports Fourth Quarter and Year-End 2010 Financial Results and Highlights
4. Anadys Pharmaceuticals Augments Management Team and Board of Directors
5. Anadys Pharmaceuticals to Present at the Lazard Healthcare Conference
6. Anadys Pharmaceuticals to Report Fourth Quarter and Year End 2009 Financial Results
7. Anadys Pharmaceuticals Receives FDA Clearance of Phase II Protocol to Study ANA598 in Combination With Interferon-Alpha and Ribavirin in HCV Patients
8. Anadys Pharmaceuticals Reports Second Quarter 2009 Financial Results and Program Highlights
9. Anadys Pharmaceuticals to Report Second Quarter 2009 Financial Results
10. Anadys Pharmaceuticals, Inc. Announces Strategic Restructuring to Focus Operations on Continuing the Advancement of ANA598
11. Anadys Pharmaceuticals Reports First Quarter 2009 Financial Results and Highlights
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/11/2014)... 2014 The Registration Committee today ... now open for Pittcon 2015, the world’s largest ... event will be held March 8-12, 2015, at ... , The discounted registration fee of $175 ... 2/20/2015). This affordable price includes unlimited week-long access ...
(Date:9/11/2014)... /PRNewswire/ - Portage Biotech Inc. ("Portage" or "the Company") ... it intends to conduct a Private Placement to ... its preclinical development activities and financial commitments to ... The Company is proposing to complete a non-brokered ... at a price of US$0.10 per Share, for ...
(Date:9/11/2014)... Awarded annually by Germany’s Design Zentrum Nordrhein-Westfalen, ... quality label for excellent design. METTLER TOLEDO is ... Red Dot award in recognition of high ... (HPD). , The Quantos Handheld Powder Dispenser ... to applications involving free-flowing powders. Forget the delicacy ...
(Date:9/11/2014)... and LONDON , ... Cancer Research Technology (CRT), the charity,s development and ... (OTCBB: ASTY), a biotechnology company in the emerging ... novel immunotherapy treatment AST-VAC2 into clinical trials in ... AST-VAC2 represents the tenth treatment to enter Cancer ...
Breaking Biology Technology:Conferee Registration Opens for Pittcon 2015; Housing & Travel Open for Reservations 2Portage Announces Proposed Private Placement 2Portage Announces Proposed Private Placement 3Portage Announces Proposed Private Placement 4METTLER TOLEDO Handheld Powder Receives Red Dot Award for Product Design 2Cancer Research UK, Cancer Research Technology And Asterias Biotherapeutics Partner To Trial Immunotherapy Vaccine For Lung Cancer 2Cancer Research UK, Cancer Research Technology And Asterias Biotherapeutics Partner To Trial Immunotherapy Vaccine For Lung Cancer 3Cancer Research UK, Cancer Research Technology And Asterias Biotherapeutics Partner To Trial Immunotherapy Vaccine For Lung Cancer 4Cancer Research UK, Cancer Research Technology And Asterias Biotherapeutics Partner To Trial Immunotherapy Vaccine For Lung Cancer 5Cancer Research UK, Cancer Research Technology And Asterias Biotherapeutics Partner To Trial Immunotherapy Vaccine For Lung Cancer 6Cancer Research UK, Cancer Research Technology And Asterias Biotherapeutics Partner To Trial Immunotherapy Vaccine For Lung Cancer 7Cancer Research UK, Cancer Research Technology And Asterias Biotherapeutics Partner To Trial Immunotherapy Vaccine For Lung Cancer 8
... Ariz., April 4, 2012  MedPlast, Inc., a technology ... Healthcare and Industrial specialty markets, announces the acquisition ... a world-class, full-service manufacturer of precision plastic products ... Datacenter markets, with operations in the U.S., China, ...
... Lian, assistant professor in the Department of Mechanical, Aerospace, ... a prestigious Faculty Early Career Development Award (CAREER) from ... the five-year, $500,000 award to further his research into ... systems. The CAREER Award is given to faculty members ...
... April 3, 2012  Oxford Finance LLC ("Oxford"), a specialty ... and healthcare services companies, today announced a $15 million ... The financing package, which was awarded to NanoString from ... million senior secured term loan and a $2 million ...
Cached Biology Technology:MedPlast Acquires UPG 2MedPlast Acquires UPG 3Rensselaer professor Jie Lian receives NSF CAREER Award 2Oxford Finance and Silicon Valley Bank Provide $15 Million Senior Credit Facility to NanoString Technologies 2Oxford Finance and Silicon Valley Bank Provide $15 Million Senior Credit Facility to NanoString Technologies 3
(Date:9/11/2014)... Northeastern University researchers and their international colleagues have ... role of neutral evolution in the biogeographic distribution ... Thursday in the journal Science . The ... a neutral agent-based model"was co-authored by Ferdi Hellweger, ... of civil and environmental engineering; his doctoral student ...
(Date:9/11/2014)... Sept. 11, 2014 /PRNewswire-iReach/ -- Today at the TEDMED ... patient portal that puts genome sequencing results at the ... and actionable. The $1000 was announced earlier ... to be the tipping point towards widespread adoption of ... billion letters and 4 million variants per human genome, ...
(Date:9/11/2014)... 2014 NXT-ID, Inc. (Nasdaq: NXTD ), ... market, announced today that its shares of common stock and ... Nasdaq Capital Market. The common stock and warrants and will ... today, the Company,s common stock will no longer be quoted ... will now be traded on Nasdaq. About ...
Breaking Biology News(10 mins):Microbes evolve faster than ocean can disperse them 2Tute Genomics Launches MyGene Portal for Genome-guided Medicine 2Tute Genomics Launches MyGene Portal for Genome-guided Medicine 3
... irritants such as air pollution and cigarette smoke cause people ... Journal of Respiratory and Critical Care Medicine . The authors ... of Hull, have identified the reaction inside the lungs that ... irritants in the air. They suggest that their findings may ...
... release is available in German . ... in the atmosphere where it contributes to global warming. The ... as forests, grasslands and peat-lands. Stimulating this "free service" of ... immediately available ways of reducing climate change. However, new greenhouse ...
... A butterfly,s proboscis looks like a straw -- long, slender, ... a paper towel, according to Konstantin Kornev of Clemson University. ... insect anatomy to make small probes that can sample the ... next week at the 62nd Annual Meeting of the American ...
Cached Biology News:Research reveals exactly how coughing is triggered by environmental irritants 2Intensive land management leaves Europe without carbon sinks 2
Recognizes the VZV nucleocapsid by indirect immunofluorescence and immunoprecipitation. Shows cross-reactivity to HSV....
Duck polyclonal to Cobra venom - Fab Fragment ( Abpromise for all tested applications). Antigen: Snake Venom of N. naja arta...
LIGHT DIAGNOSTICS Echovirus Blend Reagent, ~50 tests, included in kit #3340 & #3365...
ICAD / DFF45 (NT) Affinity Purified Polyclonal Antibody...
Biology Products: